Cargando…
Delayed Liver Function Impairment Secondary to Interferon β-1a Use in Multiple Sclerosis
Interferon β-1a is a widely used immunomodulation treatment for multiple sclerosis. Liver function impairment is a common side effect and usually develops in the first 6 months after interferon use. Here, we describe 2 multiple sclerosis patients who developed delayed liver function impairment 5 yea...
Autores principales: | Liao, Ming-Feng, Yen, Su-Chen, Chun-Yen, Lin, Rong-Kuo, Lyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728605/ https://www.ncbi.nlm.nih.gov/pubmed/23904853 http://dx.doi.org/10.1159/000354042 |
Ejemplares similares
-
Feasible Isolated Liver Transplantation for a Cirrhotic Patient on Chronic Hemodialysis
por: Morita, Kazutoyo, et al.
Publicado: (2013) -
Primary Dermal Melanoma in a Patient with a History of Multiple Malignancies: A Case Report with Molecular Characterization
por: Sini, Germana, et al.
Publicado: (2013) -
A Rare Case of Type I RenalTubular Acidosis with Membranous Nephropathy Presenting as Hypokalemic Paralysis
por: Sunder, Sham, et al.
Publicado: (2013) -
Vertebral Artery Dissection Associated with Generalized Convulsive Seizures: A Case Report
por: Amin, Faisal Mohammad, et al.
Publicado: (2013) -
Breast Osteosarcoma 29 Years after Radiation Therapy for Epithelial Breast Cancer
por: Nwankwo, Nwabundo, et al.
Publicado: (2013)